Characteristics | Group A (mPAP ≤ 20 mmHg) | Group B (25 mmHg > mPAP > 20 mmHg) | Group C (mPAP ≥ 25 mmHg) | p value | A and B | A and C | B and C |
---|---|---|---|---|---|---|---|
Case number (%) | 62 (28.4%) | 34 (15.6%) | 122 (56%) | ||||
Age (years) | 52.1 ± 12.6 | 57.9 ± 14.0 | 56.3 ± 11.3 | 0.035 | 0.026 | 0.025 | 0.513 |
Gender (male/female) | 29/33 | 18/16 | 56/66 | 0.57 | 0.979 | 0.404 | 0.467 |
BMI (kg/m2) | 24.9 ± 3.5 | 25.5 ± 4.5 | 24.3 ± 3.2 | 0.227 | 0.585 | 0.053 | 0.141 |
BSA (m2) | 1.76 ± 0.19 | 1.76 ± 0.18 | 1.70 ± 0.18 | 0.075 | 0.975 | 0.043 | 0.149 |
SBP (mmHg) | 133.2 ± 20.3 | 129.9 ± 18.3 | 130.5 ± 19.8 | 0.717 | 0.549 | 0.448 | 0.902 |
DBP (mmHg) | 81.3 ± 12.7 | 80.3 ± 11.5 | 83.9 ± 13.9 | 0.386 | 0.799 | 0.269 | 0.296 |
NT-proBNP (pg/mL) | 54 (20–83) | 70 (38.8–121.5) | 519 (179–1284) | < 0.001* | 0.377 | < 0.001* | < 0.001* |
Heart rate (bpm) | 70 ± 11 | 66 ± 7 | 74 ± 13 | 0.03 | 0.239 | 0.106 | 0.016 |
6MWD (m) | 530 (442–580) | 472.0 (430–533.5) | 393.5 (300–460) | < 0.001* | 0.614 | < 0.001* | < 0.001* |
Hemodynamics | |||||||
MPA SO% | 74.2 ± 6.4 | 71.6 ± 3.8 | 65.8 ± 9.8 | < 0.001* | 0.412 | 0.009 | 0.004 |
Aorta SO% | 99.4 ± 1.3 | 98.9 ± 2.0 | 98.3 ± 2.8 | 0.03 | 0.412 | 0.009 | 0.317 |
mPAP (mmHg) | 15.2 ± 3.2 | 22.9 ± 1.1 | 40.6 ± 10.6 | < 0.001* | < 0.001* | < 0.001* | < 0.001* |
mRAP (mmHg) | 2 (0.8–4) | 3 (1–5) | 5 (2–7) | < 0.001* | 0.032 | < 0.001* | 0.062 |
mRVP (mmHg) | 9.5 (8–12) | 14 (12–17) | 26 (21–31) | < 0.001* | 0.017 | < 0.001* | < 0.001* |
PAWP (mmHg) | 9.2 ± 3 | 11.1 ± 2.3 | 9.4 ± 2.8 | 0.017 | 0.008 | 0.76 | 0.007 |
PVR (Wood U) | 1.3 (0.7–1.8) | 2.6 (2.0–2.8) | 9.6 (6.3–13.8) | < 0.001* | 0.033 | < 0.001* | < 0.001* |
CO (L/min) | 4.6 ± 1.3 | 3.9 ± 0.7 | 3.3 ± 1.0 | < 0.001* | 0.012 | < 0.001* | 0.025 |
CI (L/min/m2) | 2.6 ± 0.7 | 2 .2 ± 0.4 | 2.0 ± 0.6 | < 0.001* | 0.009 | < 0.001* | 0.04 |
Diagnosis | |||||||
CPE | 55 | 34 | 113 | ||||
Takayasu arteritis | 4 | ||||||
Fibrosing mediastinitis | 2 | ||||||
Behcet syndrome | 1 | ||||||
IPAH | 5 | ||||||
PVOD | 3 | ||||||
PCH | 1 |